Paul J Sekhri bought $200k of APMD
director at Apnimed, Inc.. 12,500 shares at an average of $16.00, traded Aug 3, 2026, filed Aug 3, 2026.
Score components
- +15RoleDirector
- +12Trade size$200k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-330507, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | POpen-market purchase Common Stock | +12,500 | $16.00 | $200k | 12,500 | Aug 3, 2026 |
| Aug 3, 2026 | DDisposition to issuer Stock Option (Right to Buy)derivative | -169,468 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | AGrant or award Stock Option (Right to Buy)derivative | +169,468 | $0.00 | $0 | 169,468 | Aug 3, 2026 |
| Jul 30, 2026 | AGrant or award Stock Option (Right to Buy)derivative | +155,558 | $0.00 | $0 | 155,558 | Aug 3, 2026 |
| Aug 3, 2026 | DDisposition to issuer Stock Option (Right to Buy)derivative | +155,558 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | AGrant or award Stock Option (Right to Buy)derivative | +155,558 | $0.00 | $0 | 155,558 | Aug 3, 2026 |
| Jul 30, 2026 | AGrant or award Stock Option (Right to Buy)derivative | +22,238 | $0.00 | $0 | 22,238 | Aug 3, 2026 |
| Aug 3, 2026 | DDisposition to issuer Stock Option (Right to Buy)derivative | -22,238 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | AGrant or award Stock Option (Right to Buy)derivative | +22,238 | $0.00 | $0 | 22,238 | Aug 3, 2026 |
Related signals
Other insiders at Apnimed, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | Apnimed, Inc. | Morningside Venture Investments Ltd owner | $5.0M 312,500 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.